A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Penumbra Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 42,600 shares of PEN stock, worth $10.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,600
Previous 101,000 57.82%
Holding current value
$10.2 Million
Previous $18.2 Million 54.49%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.64 - $210.12 $56.1 Million - $72.1 Million
343,005 Added 496.98%
412,023 $80 Million
Q2 2024

Aug 14, 2024

BUY
$172.27 - $223.95 $4.53 Million - $5.89 Million
26,303 Added 61.58%
69,018 $12.4 Million
Q1 2024

May 15, 2024

SELL
$220.09 - $273.15 $10.7 Million - $13.3 Million
-48,719 Reduced 53.28%
42,715 $9.53 Million
Q4 2023

Feb 14, 2024

SELL
$181.44 - $260.22 $28.5 Million - $40.9 Million
-157,131 Reduced 63.22%
91,434 $23 Million
Q3 2023

Nov 14, 2023

SELL
$240.69 - $338.77 $16.2 Million - $22.9 Million
-67,478 Reduced 21.35%
248,565 $60.1 Million
Q2 2023

Aug 14, 2023

BUY
$271.54 - $344.06 $4.15 Million - $5.25 Million
15,267 Added 5.08%
316,043 $109 Million
Q1 2023

May 15, 2023

BUY
$220.43 - $278.69 $21 Million - $26.5 Million
95,126 Added 46.26%
300,776 $83.8 Million
Q4 2022

Feb 14, 2023

SELL
$151.88 - $228.5 $34.5 Million - $51.9 Million
-226,919 Reduced 52.46%
205,650 $45.7 Million
Q3 2022

Nov 14, 2022

BUY
$120.36 - $205.88 $12.8 Million - $21.8 Million
105,936 Added 32.43%
432,569 $82 Million
Q2 2022

Aug 15, 2022

SELL
$116.09 - $227.33 $4.7 Million - $9.21 Million
-40,516 Reduced 11.04%
326,633 $40.7 Million
Q1 2022

May 16, 2022

BUY
$187.51 - $283.98 $3.1 Million - $4.69 Million
16,522 Added 4.71%
367,149 $81.6 Million
Q4 2021

Feb 14, 2022

SELL
$238.08 - $288.0 $24.1 Million - $29.2 Million
-101,237 Reduced 22.4%
350,627 $101 Million
Q3 2021

Nov 15, 2021

SELL
$250.72 - $291.24 $8.18 Million - $9.5 Million
-32,614 Reduced 6.73%
451,864 $120 Million
Q2 2021

Aug 16, 2021

BUY
$235.0 - $310.7 $47.5 Million - $62.9 Million
202,335 Added 71.71%
484,478 $133 Million
Q1 2021

May 17, 2021

BUY
$175.6 - $291.43 $4.02 Million - $6.67 Million
22,892 Added 8.83%
282,143 $76.3 Million
Q4 2020

Feb 16, 2021

BUY
$174.98 - $272.83 $33.4 Million - $52.2 Million
191,162 Added 280.75%
259,251 $45.4 Million
Q3 2020

Nov 16, 2020

SELL
$185.27 - $238.73 $21.8 Million - $28.1 Million
-117,623 Reduced 63.34%
68,089 $13.2 Million
Q2 2020

Aug 14, 2020

BUY
$153.32 - $191.72 $24.2 Million - $30.3 Million
157,818 Added 565.78%
185,712 $33.2 Million
Q1 2020

May 15, 2020

SELL
$124.34 - $193.76 $1.02 Million - $1.59 Million
-8,215 Reduced 22.75%
27,894 $4.5 Million
Q4 2019

Feb 14, 2020

SELL
$134.81 - $177.8 $38.8 Million - $51.2 Million
-287,923 Reduced 88.86%
36,109 $5.93 Million
Q3 2019

Nov 14, 2019

BUY
$131.82 - $183.4 $28.8 Million - $40.1 Million
218,785 Added 207.88%
324,032 $43.6 Million
Q2 2019

Aug 14, 2019

BUY
$124.65 - $167.39 $11 Million - $14.7 Million
87,960 Added 508.82%
105,247 $16.8 Million
Q1 2019

May 15, 2019

SELL
$115.84 - $160.31 $6.33 Million - $8.75 Million
-54,606 Reduced 75.95%
17,287 $0
Q4 2018

Feb 14, 2019

SELL
$113.42 - $156.48 $3.6 Million - $4.97 Million
-31,730 Reduced 30.62%
71,893 $8.79 Million
Q3 2018

Nov 13, 2018

SELL
$121.55 - $156.8 $11.8 Million - $15.3 Million
-97,489 Reduced 48.47%
103,623 $0
Q2 2018

Aug 10, 2018

BUY
$112.2 - $165.95 $17.1 Million - $25.3 Million
152,316 Added 312.15%
201,112 $0
Q1 2018

May 11, 2018

SELL
$84.6 - $126.1 $1.17 Million - $1.75 Million
-13,883 Reduced 22.15%
48,796 $5.64 Million
Q4 2017

Feb 09, 2018

SELL
$91.55 - $115.85 $5.6 Million - $7.08 Million
-61,120 Reduced 49.37%
62,679 $5.9 Million
Q3 2017

Nov 09, 2017

BUY
$79.65 - $90.3 $9.86 Million - $11.2 Million
123,799
123,799 $11.2 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.06B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.